Key takeaways
- Functional appetite suppression typically continues 7-10 days after the last dose.
- Native GLP-1 — the hormone your gut releases after a meal — is destroyed within about two minutes by an enzyme called DPP-4.
- A drug with a five-day half-life does not reach its plateau after one injection.
- Once you are at steady state, the peak-to-trough swing is fairly modest, which is the whole design intent of a weekly injectable.
- Because the drug is long-acting, the day of the week is a convenience, not a clinical constraint.
Almost nobody asks this question out of curiosity. They ask it because they missed a dose and do not know whether to take it, because surgery is booked, because they are travelling and want to move injection day, or because they are thinking about stopping and want to know what the exit looks like. All four answers come out of the same piece of pharmacology, so it is worth understanding once properly.
The five-day half-life, and why it exists
Native GLP-1 — the hormone your gut releases after a meal — is destroyed within about two minutes by an enzyme called DPP-4 (Deacon et al., J Clin Endocrinol Metab 1995). That is fine for a signal meant to last one meal, and useless as a medication. Tirzepatide is engineered around that problem: the peptide backbone is modified to resist enzymatic breakdown, and a fatty acid chain is attached so the molecule binds reversibly to albumin in the blood and is released slowly.
The result is a half-life of roughly five days — meaning that five days after a dose, about half of it is still circulating (Schneck et al., CPT Pharmacometrics Syst Pharmacol 2024). That single number explains nearly everything else about how the medication behaves.
Why the first month feels different from the third
A drug with a five-day half-life does not reach its plateau after one injection. Each weekly dose lands on top of the residue of the previous ones, and the level in your blood climbs week over week until the amount cleared per week equals the amount injected per week. That equilibrium is called steady state, and with tirzepatide it takes roughly four weeks of consistent dosing to arrive.
Practically, this means the fourth week at any given dose is a fair test of that dose and the first week is not. People routinely draw conclusions far too early — "this dose isn't doing anything" after seven days, or the reverse, "the side effects are unbearable" during the first days of an escalation when levels are still climbing. Both readings are premature. It is also why physicians hold a dose for four weeks before escalating: they are waiting to see the true effect, not the ramp.
What the week actually looks like
- Hour 0 — injection.
- Day 1–2 — blood concentration peaks. Nausea and other gastrointestinal effects, if they happen, tend to cluster here.
- Day 3–5 — appetite suppression is typically at its most noticeable.
- Day 5 — one half-life has elapsed from that dose.
- Day 7 — trough. At steady state, most people still have substantial appetite suppression here.
Once you are at steady state, the peak-to-trough swing is fairly modest, which is the whole design intent of a weekly injectable. If you feel a pronounced "wearing off" late in week — a real return of food noise on day six or seven — that is worth mentioning at your next check-in. It is a recognised pattern and it is a dosing conversation, not something to solve by injecting early.
Moving your injection day
Because the drug is long-acting, the day of the week is a convenience, not a clinical constraint. Shifting injection day is generally straightforward as long as there are at least three days between the old dose and the new one. If you want to move from Sunday to Wednesday, moving forward by three days is usually the cleaner direction than pulling the next dose earlier. Confirm the plan with your prescriber rather than improvising it, particularly during a titration step.
Missed doses
| Time since your normal dose day | What to do |
|---|---|
| Within 4 days | Take the dose when you remember, then resume your usual schedule. |
| More than 4 days | Skip it. Take the next dose on your regular day. |
| Two or more weeks missed | Contact your prescriber before restarting. Restarting at full dose after a long gap is a common cause of avoidable side effects. |
The four-day rule exists to protect the gap between doses. Never double up to "catch up" — you are not making up lost ground, you are stacking a peak on top of a peak, and the gastrointestinal consequences of that are the predictable part.
The last row matters more than people expect. Tolerance to the gastrointestinal effects builds during titration and it fades when the drug clears. Someone who was comfortable at a higher dose in March and stops for a month is not necessarily comfortable at that same dose in May. Prescribers frequently step the dose back down and re-escalate after an extended gap. That is not lost progress; it is the fastest route back to a dose you can actually stay on.
What the exit looks like
Full clearance takes roughly five half-lives, which lands around 25 days. But "cleared" and "no longer working" are different milestones, and the second one arrives first:
- Day 1–7 — the drug is still substantially present and appetite suppression continues largely unchanged.
- Day 7–14 — appetite returns gradually. Most people notice it as food re-entering their attention rather than as sudden hunger.
- Day 14–21 — most of the appetite effect is gone.
- Day 25 or so — effectively fully cleared.
The delay is the part that catches people out. Someone who stops and feels fine for the first ten days may conclude they never needed the medication, then meet the full return of appetite in week three with no plan in place. If you are stopping deliberately, the maintenance structure — protein, training, and a monitoring plan — needs to be running before the drug clears, not assembled afterwards. See what happens when you stop semaglutide for how the regain pattern plays out; it is broadly similar for tirzepatide.
Surgery, anaesthesia and endoscopy
This is the one section with a genuine safety issue behind it. GLP-1 receptor agonists slow gastric emptying. Under anaesthesia, protective airway reflexes are suppressed, so food still sitting in the stomach after a standard pre-operative fast creates an aspiration risk. There have been enough reported cases that anaesthesiology bodies have issued specific guidance (Kang et al., Korean J Intern Med 2026).
- Elective surgery — hold the medication for one to two weeks before the procedure, per your surgical team's instruction.
- Endoscopy — a minimum of one week, often two; residual stomach contents also compromise the examination itself.
- Urgent or emergency procedures — the anaesthesiology team can manage this with precautions, including treating you as a full stomach and adjusting airway technique.
- Always disclose it. Tell the surgeon, the anaesthesiologist and the pre-op nurse that you are on a GLP-1 medication, including the dose and the date of your last injection. Do not assume it transferred across from your medication list.
That last point is the one that actually goes wrong. Patients often do not think of a weekly weight-management injection as a "medication" in the sense the intake form is asking about. It is, and the date of the last dose is the number the anaesthetist needs.
The principle: A five-day half-life is what makes once-weekly dosing possible. The same property means the drug takes about a month to reach full effect, about three weeks to stop working after you quit, and one to two weeks to clear enough for safe anaesthesia. Every practical question about timing traces back to that one number.
Bottom line
Tirzepatide has a half-life of about five days and clears fully in roughly 25 days. Steady state takes about four weeks, so judge a dose at week four, not week one. A missed dose can be taken within four days; beyond that, skip it, and after a gap of two weeks or more, talk to your prescriber before restarting rather than resuming at your old dose. Appetite typically returns one to three weeks after stopping. Hold for one to two weeks before elective surgery or endoscopy, and tell every member of the surgical team the date of your last injection.
Educational content, not medical advice. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary. Dosing, missed-dose handling and pre-procedure instructions are determined by your prescribing physician.
